The markets opened flat with the Dow holding steady at 21,206 after another terrorist attack in London on Saturday. Nasdaq edged up a point to 6,307.
On the upside
D.R. Horton (NYSE: DHI) offered a premium of $16.25 per share in cash to acquire 75% of Forestar Group (NYSE: FOR).
Puma Biotechnology (Nasdaq: PBYI) reported positive results from a Phase II clinical trial of PB272 to treat HER2-positive metastatic breast cancer.
Gigamon (NYSE: GIMO) will engage in discussions with potential suitors.
On the downside
Juno Therapeutics (Nasdaq: JUNO) presented updated data from the TRANSCEND trial of JCAR017 in relapsed and refractory aggressive B cell non-Hodgkin lymphoma.
Herbalife (NYSE: HLF) warned that second quarter revenue would fall more than expected.
Mallinckrodt (NYSE: MNK) may sell its generic drug business.
The broader S&P 500 eased a fraction to 2,438. Bitcoin surged $73 to $2569.
